Navigation Links
Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value
Date:7/2/2009

lth care system. Eisai employs approximately 10,000 employees worldwide.

About Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd. and supports the activities of its operating companies in North America. These operating companies include: Eisai Research Institute of Boston, Inc., a discovery operation with strong organic chemistry capabilities; Morphotek, Inc., a biopharmaceutical company specializing in the development of therapeutic monoclonal antibodies; Eisai Medical Research Inc., a clinical development group; Eisai Inc., a commercial operation with manufacturing and marketing/sales functions; and Eisai Machinery U.S.A., which markets and maintains pharmaceutical manufacturing machinery. For more information about Eisai, please visit www.eisai.com.


'/>"/>
SOURCE Eisai Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer
2. New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal
3. Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions
4. Walter Reed Army Medical Center offers HIFU for Qualifying Men with Locally Recurrent Prostate Cancer in a Phase III Clinical Trial
5. Angiomax Will Retain Decision Resources Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI
6. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
7. NanoBio Demonstrates New Topical Approach to Treating Nail Fungus That Circumvents Problems with Current Therapy
8. Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials
9. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
10. Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
11. Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...RRY HILL, N.J., Dec. 1 F...rprised and delighted when his radiotherapy treatm...0 minutes each day to less than five. Midway thro...are Valley Urology Cancer Center acquired the re...gy from Varian Medical Systems (NYSE: VAR ), ma...
(Date:12/1/2009)... Calif., Dec. 1 The new position o...Microchip Biotechnologies, Inc. has been taken up ...ve with more than 30 years of experience creating ...r. Goldstein will direct Microchip Biotechnologies...mer service operations as the company makes the tr...
(Date:12/1/2009)... and TOKYO, Dec. 1 Galenea Corp. a... the further extension of their research and devel...tension increases the collaboration term to seven ...proximately $90 million. The companies have been ...of discovering and developing first-in-class thera...
Breaking Medicine Technology:Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3First Pediatric Patient Treated With Aptocine 28TM 29 a Novel Light Activated Drug in Neurofibromatosis Study 13528 1First Pediatric Patient Treated With Aptocine 28TM 29 a Novel Light Activated Drug in Neurofibromatosis Study 13528 2First Pediatric Patient Treated With Aptocine 28TM 29 a Novel Light Activated Drug in Neurofibromatosis Study 13528 3Sage Software Healthcare Inc Celebrates National Health Center Week 54311 1Sage Software Healthcare Inc Celebrates National Health Center Week 54311 2Goold Health Systems Accelerates Backups by 5 times Using Arkeia Network Backup 54309 1Goold Health Systems Accelerates Backups by 5 times Using Arkeia Network Backup 54309 2Goold Health Systems Accelerates Backups by 5 times Using Arkeia Network Backup 54309 3
...allisto Pharmaceuticals,Inc. (Amex: KAL; FWB: CA4)...against cancer and inflammatory diseases, announce...clinical trial of Atiprimod to treat low to,interm...rcinoid cancer).,With the addition of the Robert H...n University, 676 N. St. Clair Street, Suite 850, ...
... Give Molecular Laboratories Increased Efficiencie... Test, Which Surpasses, Standard-of-Care Sensitiv... Measure All Known Strains of HIV-1,...has received a supplemental Premarket Approval fro...cently introduced RealTime HIV-1 viral load test.,...
Other Medicine Technology:Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients 2Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients 3Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients 4Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 2Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 3Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 4Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 5Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 6
(Date:12/1/2009)...ld identify those who would benefit from liver sur...DAY, Dec. 1 (HealthDay News) -- A CT scan of liver...may help predict overall survival after chemothera...vastin) to cytotoxic chemotherapy has been shown t...orectal cancer and to produce better results in pa...
(Date:12/1/2009)...HILADELPHIA (December 1, 2009) Wistar Institute ...of Pennsylvania and New York University have ident...icate early-stage lung tumors in people at high ri...shed online December 1 in Cancer Research , a jou...ch, could lead to a simple blood test to detect lu...
(Date:12/1/2009)... Ever thought you could quit...Kevin Arthur Smith,s groundbreaking new system for... permanent. In just twenty eight days your craving..., (PRWEB) December 1, 2009...ing her eight-year addiction to nicotine, smoking ...
(Date:12/1/2009)... , LEHIGH VALLEY, Pa., Dec. 1 /PRNewswire-Fi... it has completed the previously announced sale of...ess, marketed under the Airthane® and Versath...ed subsidiary of global polyurethane chemicals pro...r Products, manufacturing facility in Paulsboro, N...
(Date:12/1/2009)... , WASHINGTON, Dec. 1 /PRNewswire-USNewswire/...ency for International Development: ,, Chairman...ommittee. ,, I am honored to be nominated by Pr...ted States Agency for International Development, a...gency. ,, Secretary of State Clinton has expre...
Breaking Medicine News(10 mins):Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 4Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 5Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 6Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 7Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 8Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 9
... Demonstrated, ROCKVILLE, Md., Dec. 10 EntreMed,...tical company developing,therapeutics for the trea...nnounced the presentation of preclinical results i... Dr. Maria,Kavallaris, at the American Society of ...
...ehabilitation and the University of Florida have r...n the Brooks Center for Rehabilitation Studies,in ...acility., The agreement increases funding for the...through its Health,Science Center colleges, will p...
...oVaccine Technologies Inc. (IVT),a Nova Scotia-bas...ng,memorandum of understanding to acquire Immunoto...y developing immunotherapy products,for the treatm...tfolio of immunotherapeutic antigens and,antigen d...
...os Addresses Objectives from the Joint, Commission...and Institute for Healthcare... National Forum on,Quality Improvement in Health C...egulations Package, a comprehensive,compilation of...
...he nation,s leading,supplier of replacement medica...ognized as a 2007 Pillar Award winner for communit...that have distinguished themselves,through leading...resources to help people around the world receive ...
...to be held Thursday, January 17, at ...Calif., Dec. 10 Cardica, Inc.,(Nasdaq: CRDC ) to...he Heart,Hospital Baylor Plano and Centennial Medi...ng innovative anastomotic,devices from Cardica, In...
Other Medicine News:Health News:EntreMed Presents Results for ENMD-1198 and Vincristine in Preclinical Leukemia Models 2Health News:EntreMed Presents Results for ENMD-1198 and Vincristine in Preclinical Leukemia Models 3Health News:Brooks and the University of Florida Reach Research Agreement 2Health News:ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc. 2Health News:GetWellNetwork Offers Comprehensive Education Package Enabling Hospitals to Meet Compliance Requirements for Patient Education 2Health News:GetWellNetwork Offers Comprehensive Education Package Enabling Hospitals to Meet Compliance Requirements for Patient Education 3Health News:GetWellNetwork Offers Comprehensive Education Package Enabling Hospitals to Meet Compliance Requirements for Patient Education 4Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 2Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 3Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 4Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 5
...rosol Resistant Tips offer a safe alternative to u... designed for applications such as PCR(a), pipetti...ddition, ART Tips are excellent for tissue culture...dies. ART Tips prevent aerosol contaminants and li...
Tipack (Sterilized) D1000
MBP 1000GGenomic Tip
...Premium Low Binding, Graduated, Long Reach Pipet T...d protein binding. Non-reactive. Beveled and refer...s up to 10 L. Produced & packaged completely by au...e Racked packaged 96 tips/rack and 10 racks/cs. AV...
Medicine Products: